Lung transplantation in infants and toddlers from 1990 to 2004 at St. Louis Children's Hospital

A Elizur1, A Faro, C B Huddleston

  • 1Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO, USA.

Insights

Lung transplantation in young children shows comparable survival rates to older patients. Infants and toddlers experienced less acute rejection and fewer cases of bronchiolitis obliterans post-transplant.

Area of Science:

  • Pediatric surgery
  • Thoracic surgery
  • Transplantation immunology

Background:

  • Lung transplantation outcomes vary significantly by age group.
  • Data on infant and toddler lung transplant recipients is limited.
  • Understanding age-specific challenges is crucial for optimizing post-transplant care.

Purpose of the Study:

  • To compare lung transplant outcomes in infants and toddlers versus older children.
  • To evaluate graft survival, rejection rates, and functional recovery across age groups.
  • To identify unique challenges and potential immunologic factors in pediatric lung transplantation.

Main Methods:

  • Retrospective, single-center cohort study.
  • Comparison of 109 lung transplants performed between 1990-2004.
  • Exclusion of specific conditions like cystic fibrosis and re-transplantations.

Main Results:

  • Graft survival was similar across age groups (infants, toddlers, >3 years) at 1 and 3 years post-transplant.
  • Infants and toddlers had significantly lower rates of acute rejection and bronchiolitis obliterans.
  • Most young recipients showed minimal lung function impairment and near-normal development, but depressed somatic growth persisted at 5 years.

Conclusions:

  • Lung transplantation in infants and young children yields survival rates comparable to older children and adults.
  • Younger recipients demonstrate improved outcomes regarding acute and chronic rejection.
  • Further research into immunologic differences may inform strategies to prevent rejection in all lung transplant patients.